Universe Pharmaceuticals's market cap is currently $1.23M. The company's EPS TTM is $-5.096; its P/E ratio is ―; Universe Pharmaceuticals is scheduled to report earnings on February 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	$ 32.31M	$ 40.14M	$ 47.98M	$ 30.70M	$ 33.23M
Gross Profit	$ 10.32M	$ 21.89M	$ 25.33M	$ 14.09M	$ 13.41M
Operating Income	$ -3.53M	$ -7.02M	$ 13.59M	$ 10.25M	$ 9.75M
EBITDA	$ -3.22M	$ -7.33M	$ 14.20M	$ 10.61M	$ 10.17M
Net Income	$ -6.16M	$ -8.74M	$ 11.32M	$ 7.56M	$ 7.55M
Balance Sheet
Cash & Short-Term Investments	$ 18.50M	$ 18.86M	$ 21.80M	$ 10.06M	$ 3.18M
Total Assets	$ 53.29M	$ 59.54M	$ 70.14M	$ 28.80M	$ 17.84M
Total Debt	$ 5.48M	$ 3.94M	$ 4.33M	$ 2.65M	$ 2.52M
Net Debt	$ 197.21K	$ -1.78M	$ -3.74M	$ -7.41M	$ -655.52K
Total Liabilities	$ 13.75M	$ 13.10M	$ 11.21M	$ 8.00M	$ 5.45M
Stockholders' Equity	$ 39.53M	$ 46.44M	$ 58.93M	$ 20.80M	$ 12.38M
Cash Flow
Free Cash Flow	$ 1.08M	$ -1.41M	$ -15.59M	$ 6.06M	$ 13.12M
Operating Cash Flow	$ 1.12M	$ -1.31M	$ -2.06M	$ 6.12M	$ 13.20M
Investing Cash Flow	$ -44.17K	$ -3.91M	$ -27.06M	$ -51.80K	$ -86.03K
Financing Cash Flow	$ -1.39M	$ 3.32M	$ 26.58M	$ 470.14K	$ -16.00M

Currency in USD

Universe Pharmaceuticals Earnings and Revenue History

Income Statement >

Universe Pharmaceuticals Debt to Assets

Balance Sheet >

Universe Pharmaceuticals Cash Flow

Cash Flow >

Universe Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing